Identity
- Trade Name
- A.C.S® (Alcon Closure System), PAIR-PAK II® FDA UDI
- Generic Name
- Nylon suture, non-bioabsorbable, monofilament FDA UDI
- Device Name
- Suture 1 - Needle Type CU-1, Black Monofilament Nylon(BMN), Suture Size 10-0, Suture Length 12" / Suture 2 - Needle Type PC-5, Black Braided Silk(BBS), Suture Size 4-0, Suture Lenght 30" FDA UDI
- Model / Reference
- 8065307201 FDA UDI
- Description
- Suture 1 - Needle Type CU-1, Black Monofilament Nylon(BMN), Suture Size 10-0, Suture Length 12" / Suture 2 - Needle Type PC-5, Black Braided Silk(BBS), Suture Size 4-0, Suture Lenght 30" FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00380653072013 FDA UDI
- FDA Product Code
- GAR FDA UDIGAP FDA UDI
- GMDN Term
- Nylon suture, non-bioabsorbable, monofilament FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 878.5020 FDA UDI878.5030 FDA UDI
- Commercial Distribution
- Not in Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
Yes
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
Yes
FDA UDI
Dimensions & Sizes
- Size
- Length — 30 Inch FDA UDILength — 12 Inch FDA UDI
A.C.S® (Alcon Closure System), PAIR-PAK II® by Alcon Laboratories, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Alcon Laboratories, Inc.
Sources (1)
- FDA UDI 3e4efb5f-80ae-4124-8ac7-14d6873e4e87 36 fields · synced Jun 6, 2026